PUBLIC PORTAL

MEDICALLY REVIEWED

A Milestone in GLP-1RA Therapy: Oral Semaglutide (Rybelsus)

Share on email
Share on print
Share on whatsapp

Semaglutide tablet (Rybelsus), the first GLP-1RA developed for oral administration, heralds a milestone for diabetes management in the 15 years since the introduction of the first glucagon-like peptide-1 receptor agonist (GLP-1RA). Rybelsus and its parenteral counterpart, Semaglutide (Ozempic), are approved for use in the treatment of . . .

Login or Sign Up as a healthcare professional to read the full article.

Share via

Share on email
Share on facebook
Share on whatsapp
Share on telegram
Share on twitter
Share on linkedin

Also worth reading

hepatitis a

Hepatitis A: Are You At Risk?

Semaglutide tablet (Rybelsus), the first GLP-1RA developed for oral administration, heralds a milestone for diabetes management in the 15 years since the introduction of the

Read More »